News
Initial Seracam® characterization results presented at BNMS Spring Meeting, Harrogate
22/05/2023
London, UK, 22 May 2023. Serac Imaging Systems Limited (“Serac Imaging Systems” or “the Company”), the medtech company developing a portable hybrid gamma/optical camera for medical imaging, announces that an abstract titled ‘Initial characterization of the Seracam: a small-footprint gamma-optical camera, with fully automated collimator changing capabilities’ is being presented in a poster presentation at the British Nuclear Medicine Society (BNMS) Spring meeting taking place from 22-24 May 2023, in Harrogate, UK.
First clinical testing of Seracam® commences at the University of Malaya
17/05/2023
Serac Imaging Systems Limited (“Serac Imaging Systems” or “the Company”), the medtech company developing a portable hybrid gamma-optical camera for medical imaging, and the University of Malaya, today announce the start of clinical testing using the Seracam® camera.
Seracam® to be presented at Parathyroid Symposium 2023: Oral presentation on qualitative and quantitative capabilities and novel features of Seracam®
24/02/2023
London, UK, 24 Feb 2023. Serac Imaging Systems Limited (“Serac Imaging Systems” or “the Company”), the medtech company developing a portable hybrid gamma/optical camera for medical imaging, today announces that an abstract titled ‘Seracam: A first look at a new portable gamma camera’ has been selected for oral presentation at the 5th Symposium on Parathyroid Fluorescence taking place 23-24 February 2023 in Geneva, Switzerland. Abstract 17 is available here.
Initial Seracam® characterization results presented at Cancer Diagnosis Network Theranostics Workshop
22/11/2022
London, UK, 22 Nov 2022. Serac Imaging Systems Limited (“Serac Imaging Systems” or “the Company”), the medtech company developing a portable hybrid gamma/optical camera for medical imaging, today announces that an abstract titled ‘Initial characterization of the Seracam: a small-footprint gamma-optical camera, with fully automated collimator changing capabilities’ has been selected for poster presentation at the Science and Technology Facilities Council funded, Cancer Diagnosis Network Theranostics Workshop on 22 November 2022, in London, UK.
James McCutcheon FCCA, Appointed Chief Financial Officer
01/11/2021
Please join us in welcoming James to the Serac Imaging Systems team. James is an experienced commercial and finance director with over 30 years’ experience in the pharmaceutical and medical device sectors, having held senior finance positions in both large multinationals, as well as smaller fast growing SMEs.
Julie Davis, Appointed Head of Quality Management
01/08/2020
Please join us in welcoming Julie to the Serac Imaging Systems team as Head of Quality Management. Julie’s career has been spent in life science and radiopharmaceutical drug discovery, most recently consulting with biotech start-ups including leading the development and implementation of operational processes and quality systems.
Serac Imaging Systems to develop a compact, hybrid optical/gamma camera which will be portable, smaller, easier to use and more cost effective than anything that exists on the market today.
27/06/2019
Serac Imaging Systems Limited (SIS), a wholly-owned subsidiary of Serac Life Sciences Limited (SLS), is developing and commercialising a novel, compact, portable, hybrid gamma/optical camera (HGC) the IP for which has been exclusively licensed from a group of universities led by the University of Leicester.
Pat Butler, Joins as Board Observer and Advisor.
10/06/2019
Pat, a qualified Chartered Accountant, is a director of Hikma Pharmaceuticals, Chairman of Aldermore Bank and was formerly a Senior Director at McKinsey & Co. He is also a Governor of the British Film Institute and a trustee of the Resolution Foundation.